1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Pharmaceutical Serialisation Services by Type
  • 1.3.1 Overview: Global Pharmaceutical Serialisation Services Market Size by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Global Pharmaceutical Serialisation Services Consumption Value Market Share by Type in 2025
  • 1.3.3 Barcode
  • 1.3.4 QR Code
  • 1.3.5 RFID
  • 1.3.6 Others
• 1.4 Global Pharmaceutical Serialisation Services Market by Application
  • 1.4.1 Overview: Global Pharmaceutical Serialisation Services Market Size by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Pharmaceutical Manufacturing
  • 1.4.3 Pharmaceutical Distribution
  • 1.4.4 Pharmaceutical Logistics
• 1.5 Global Pharmaceutical Serialisation Services Market Size & Forecast
• 1.6 Global Pharmaceutical Serialisation Services Market Size and Forecast by Region
  • 1.6.1 Global Pharmaceutical Serialisation Services Market Size by Region: 2021 VS 2025 VS 2032
  • 1.6.2 Global Pharmaceutical Serialisation Services Market Size by Region, (2021-2032)
  • 1.6.3 North America Pharmaceutical Serialisation Services Market Size and Prospect (2021-2032)
  • 1.6.4 Europe Pharmaceutical Serialisation Services Market Size and Prospect (2021-2032)
  • 1.6.5 Asia-Pacific Pharmaceutical Serialisation Services Market Size and Prospect (2021-2032)
  • 1.6.6 South America Pharmaceutical Serialisation Services Market Size and Prospect (2021-2032)
  • 1.6.7 Middle East & Africa Pharmaceutical Serialisation Services Market Size and Prospect (2021-2032)

2 Company Profiles

• 2.1 Aphena Pharma +C581Solutions
  • 2.1.1 Aphena Pharma +C581Solutions Details
  • 2.1.2 Aphena Pharma +C581Solutions Major Business
  • 2.1.3 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product and Solutions
  • 2.1.4 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Aphena Pharma +C581Solutions Recent Developments and Future Plans
• 2.2 NNE
  • 2.2.1 NNE Details
  • 2.2.2 NNE Major Business
  • 2.2.3 NNE Pharmaceutical Serialisation Services Product and Solutions
  • 2.2.4 NNE Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 NNE Recent Developments and Future Plans
• 2.3 Sharp Services
  • 2.3.1 Sharp Services Details
  • 2.3.2 Sharp Services Major Business
  • 2.3.3 Sharp Services Pharmaceutical Serialisation Services Product and Solutions
  • 2.3.4 Sharp Services Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Sharp Services Recent Developments and Future Plans
• 2.4 Movianto
  • 2.4.1 Movianto Details
  • 2.4.2 Movianto Major Business
  • 2.4.3 Movianto Pharmaceutical Serialisation Services Product and Solutions
  • 2.4.4 Movianto Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Movianto Recent Developments and Future Plans
• 2.5 UPM Pharmaceuticals
  • 2.5.1 UPM Pharmaceuticals Details
  • 2.5.2 UPM Pharmaceuticals Major Business
  • 2.5.3 UPM Pharmaceuticals Pharmaceutical Serialisation Services Product and Solutions
  • 2.5.4 UPM Pharmaceuticals Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 UPM Pharmaceuticals Recent Developments and Future Plans
• 2.6 MSK Pharmalogisti
  • 2.6.1 MSK Pharmalogisti Details
  • 2.6.2 MSK Pharmalogisti Major Business
  • 2.6.3 MSK Pharmalogisti Pharmaceutical Serialisation Services Product and Solutions
  • 2.6.4 MSK Pharmalogisti Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 MSK Pharmalogisti Recent Developments and Future Plans
• 2.7 Covectra
  • 2.7.1 Covectra Details
  • 2.7.2 Covectra Major Business
  • 2.7.3 Covectra Pharmaceutical Serialisation Services Product and Solutions
  • 2.7.4 Covectra Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 Covectra Recent Developments and Future Plans
• 2.8 Koerber-Pharma
  • 2.8.1 Koerber-Pharma Details
  • 2.8.2 Koerber-Pharma Major Business
  • 2.8.3 Koerber-Pharma Pharmaceutical Serialisation Services Product and Solutions
  • 2.8.4 Koerber-Pharma Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 Koerber-Pharma Recent Developments and Future Plans
• 2.9 Palladio Group
  • 2.9.1 Palladio Group Details
  • 2.9.2 Palladio Group Major Business
  • 2.9.3 Palladio Group Pharmaceutical Serialisation Services Product and Solutions
  • 2.9.4 Palladio Group Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Palladio Group Recent Developments and Future Plans
• 2.10 TraceLink
  • 2.10.1 TraceLink Details
  • 2.10.2 TraceLink Major Business
  • 2.10.3 TraceLink Pharmaceutical Serialisation Services Product and Solutions
  • 2.10.4 TraceLink Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 TraceLink Recent Developments and Future Plans
• 2.11 Ultimate Solutions
  • 2.11.1 Ultimate Solutions Details
  • 2.11.2 Ultimate Solutions Major Business
  • 2.11.3 Ultimate Solutions Pharmaceutical Serialisation Services Product and Solutions
  • 2.11.4 Ultimate Solutions Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 Ultimate Solutions Recent Developments and Future Plans
• 2.12 Clarkston Consulting
  • 2.12.1 Clarkston Consulting Details
  • 2.12.2 Clarkston Consulting Major Business
  • 2.12.3 Clarkston Consulting Pharmaceutical Serialisation Services Product and Solutions
  • 2.12.4 Clarkston Consulting Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 Clarkston Consulting Recent Developments and Future Plans
• 2.13 Jones Healthcare Group
  • 2.13.1 Jones Healthcare Group Details
  • 2.13.2 Jones Healthcare Group Major Business
  • 2.13.3 Jones Healthcare Group Pharmaceutical Serialisation Services Product and Solutions
  • 2.13.4 Jones Healthcare Group Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 Jones Healthcare Group Recent Developments and Future Plans
• 2.14 MSK Pharmalogistic
  • 2.14.1 MSK Pharmalogistic Details
  • 2.14.2 MSK Pharmalogistic Major Business
  • 2.14.3 MSK Pharmalogistic Pharmaceutical Serialisation Services Product and Solutions
  • 2.14.4 MSK Pharmalogistic Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.14.5 MSK Pharmalogistic Recent Developments and Future Plans
• 2.15 Vetter-Pharma
  • 2.15.1 Vetter-Pharma Details
  • 2.15.2 Vetter-Pharma Major Business
  • 2.15.3 Vetter-Pharma Pharmaceutical Serialisation Services Product and Solutions
  • 2.15.4 Vetter-Pharma Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.15.5 Vetter-Pharma Recent Developments and Future Plans
• 2.16 NextPharma Logistics
  • 2.16.1 NextPharma Logistics Details
  • 2.16.2 NextPharma Logistics Major Business
  • 2.16.3 NextPharma Logistics Pharmaceutical Serialisation Services Product and Solutions
  • 2.16.4 NextPharma Logistics Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.16.5 NextPharma Logistics Recent Developments and Future Plans
• 2.17 OPTEL
  • 2.17.1 OPTEL Details
  • 2.17.2 OPTEL Major Business
  • 2.17.3 OPTEL Pharmaceutical Serialisation Services Product and Solutions
  • 2.17.4 OPTEL Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.17.5 OPTEL Recent Developments and Future Plans
• 2.18 Central Pharma
  • 2.18.1 Central Pharma Details
  • 2.18.2 Central Pharma Major Business
  • 2.18.3 Central Pharma Pharmaceutical Serialisation Services Product and Solutions
  • 2.18.4 Central Pharma Pharmaceutical Serialisation Services Revenue, Gross Margin and Market Share (2021-2026)
  • 2.18.5 Central Pharma Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Pharmaceutical Serialisation Services Revenue and Share by Players (2021-2026)
• 3.2 Market Share Analysis (2025)
  • 3.2.1 Market Share of Pharmaceutical Serialisation Services by Company Revenue
  • 3.2.2 Top 3 Pharmaceutical Serialisation Services Players Market Share in 2025
  • 3.2.3 Top 6 Pharmaceutical Serialisation Services Players Market Share in 2025
• 3.3 Pharmaceutical Serialisation Services Market: Overall Company Footprint Analysis
  • 3.3.1 Pharmaceutical Serialisation Services Market: Region Footprint
  • 3.3.2 Pharmaceutical Serialisation Services Market: Company Product Type Footprint
  • 3.3.3 Pharmaceutical Serialisation Services Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Pharmaceutical Serialisation Services Consumption Value and Market Share by Type (2021-2026)
• 4.2 Global Pharmaceutical Serialisation Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

• 5.1 Global Pharmaceutical Serialisation Services Consumption Value Market Share by Application (2021-2026)
• 5.2 Global Pharmaceutical Serialisation Services Market Forecast by Application (2027-2032)

6 North America

• 6.1 North America Pharmaceutical Serialisation Services Consumption Value by Type (2021-2032)
• 6.2 North America Pharmaceutical Serialisation Services Market Size by Application (2021-2032)
• 6.3 North America Pharmaceutical Serialisation Services Market Size by Country
  • 6.3.1 North America Pharmaceutical Serialisation Services Consumption Value by Country (2021-2032)
  • 6.3.2 United States Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 6.3.3 Canada Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 6.3.4 Mexico Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)

7 Europe

• 7.1 Europe Pharmaceutical Serialisation Services Consumption Value by Type (2021-2032)
• 7.2 Europe Pharmaceutical Serialisation Services Consumption Value by Application (2021-2032)
• 7.3 Europe Pharmaceutical Serialisation Services Market Size by Country
  • 7.3.1 Europe Pharmaceutical Serialisation Services Consumption Value by Country (2021-2032)
  • 7.3.2 Germany Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 7.3.3 France Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 7.3.4 United Kingdom Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 7.3.5 Russia Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 7.3.6 Italy Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

• 8.1 Asia-Pacific Pharmaceutical Serialisation Services Consumption Value by Type (2021-2032)
• 8.2 Asia-Pacific Pharmaceutical Serialisation Services Consumption Value by Application (2021-2032)
• 8.3 Asia-Pacific Pharmaceutical Serialisation Services Market Size by Region
  • 8.3.1 Asia-Pacific Pharmaceutical Serialisation Services Consumption Value by Region (2021-2032)
  • 8.3.2 China Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 8.3.3 Japan Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 8.3.4 South Korea Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 8.3.5 India Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 8.3.6 Southeast Asia Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 8.3.7 Australia Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)

9 South America

• 9.1 South America Pharmaceutical Serialisation Services Consumption Value by Type (2021-2032)
• 9.2 South America Pharmaceutical Serialisation Services Consumption Value by Application (2021-2032)
• 9.3 South America Pharmaceutical Serialisation Services Market Size by Country
  • 9.3.1 South America Pharmaceutical Serialisation Services Consumption Value by Country (2021-2032)
  • 9.3.2 Brazil Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 9.3.3 Argentina Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

• 10.1 Middle East & Africa Pharmaceutical Serialisation Services Consumption Value by Type (2021-2032)
• 10.2 Middle East & Africa Pharmaceutical Serialisation Services Consumption Value by Application (2021-2032)
• 10.3 Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country
  • 10.3.1 Middle East & Africa Pharmaceutical Serialisation Services Consumption Value by Country (2021-2032)
  • 10.3.2 Turkey Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 10.3.3 Saudi Arabia Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)
  • 10.3.4 UAE Pharmaceutical Serialisation Services Market Size and Forecast (2021-2032)

11 Market Dynamics

• 11.1 Pharmaceutical Serialisation Services Market Drivers
• 11.2 Pharmaceutical Serialisation Services Market Restraints
• 11.3 Pharmaceutical Serialisation Services Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Pharmaceutical Serialisation Services Industry Chain
• 12.2 Pharmaceutical Serialisation Services Upstream Analysis
• 12.3 Pharmaceutical Serialisation Services Midstream Analysis
• 12.4 Pharmaceutical Serialisation Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Pharmaceutical Serialisation Services market size was valued at US$ 1353 million in 2025 and is forecast to a readjusted size of US$ 1894 million by 2032 with a CAGR of 5.0% during review period.
Pharmaceutical serialisation services refer to technical services provided to pharmaceutical companies or drug distribution enterprises for drug serialization identification, tracking, and tracing. Serialization involves assigning a unique identifier (such as a barcode, qr code, etc.) to each drug to facilitate tracking and tracing throughout the supply chain. Pharmaceutical serialisation services typically include the generation and printing of serialization identifiers, the collection and storage of serialization data, and the querying and tracking of serialization information. Through pharmaceutical serialisation services, pharmaceutical companies and drug distribution enterprises can achieve full-process monitoring of drug production, distribution, and use, ensuring drug quality and safety. Additionally, pharmaceutical serialisation services can help enterprises improve supply chain transparency and efficiency, reduce operating costs, and enhance their brand image and market competitiveness.
This report is a detailed and comprehensive analysis for global Pharmaceutical Serialisation Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Serialisation Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Pharmaceutical Serialisation Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Pharmaceutical Serialisation Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Pharmaceutical Serialisation Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Serialisation Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Serialisation Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aphena Pharma +C581Solutions, NNE, Sharp Services, Movianto, UPM Pharmaceuticals, MSK Pharmalogisti, Covectra, Koerber-Pharma, Palladio Group, TraceLink, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pharmaceutical Serialisation Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Barcode
QR Code
RFID
Others
Market segment by Application
Pharmaceutical Manufacturing
Pharmaceutical Distribution
Pharmaceutical Logistics
Market segment by players, this report covers
Aphena Pharma +C581Solutions
NNE
Sharp Services
Movianto
UPM Pharmaceuticals
MSK Pharmalogisti
Covectra
Koerber-Pharma
Palladio Group
TraceLink
Ultimate Solutions
Clarkston Consulting
Jones Healthcare Group
MSK Pharmalogistic
Vetter-Pharma
NextPharma Logistics
OPTEL
Central Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical Serialisation Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical Serialisation Services, with revenue, gross margin, and global market share of Pharmaceutical Serialisation Services from 2021 to 2026.
Chapter 3, the Pharmaceutical Serialisation Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Pharmaceutical Serialisation Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Serialisation Services.
Chapter 13, to describe Pharmaceutical Serialisation Services research findings and conclusion.